Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Kendrick

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 30, 2018
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trialsDerek J Nunez, Myriam Alexander, Laura Yerges-Armstrong, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
Advances in Therapy|November 9, 2022
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database StudyIain A Gillespie, K Arnold Chan, Yunhao Liu, et al.
BMC Medicine|August 14, 2018
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver diseaseMyriam Alexander, A Katrina Loomis, Jolyon Fairburn-Beech, et al.
BMJ (Clinical Research Ed.)|October 10, 2019
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adultsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
Infectious Diseases and Therapy|September 27, 2023
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort StudiesIain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
Infectious Diseases and Therapy|July 11, 2023
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort StudiesIain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Medicine|May 21, 2019
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 30, 2018
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trialsDerek J Nunez, Myriam Alexander, Laura Yerges-Armstrong, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
Advances in Therapy|November 9, 2022
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database StudyIain A Gillespie, K Arnold Chan, Yunhao Liu, et al.
BMC Medicine|August 14, 2018
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver diseaseMyriam Alexander, A Katrina Loomis, Jolyon Fairburn-Beech, et al.
BMJ (Clinical Research Ed.)|October 10, 2019
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adultsMyriam Alexander, A Katrina Loomis, Johan van der Lei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
Infectious Diseases and Therapy|September 27, 2023
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort StudiesIain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
Infectious Diseases and Therapy|July 11, 2023
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort StudiesIain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
The New England Journal of Medicine|November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B InfectionMan-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Pageof 4